XenoPort, Inc. (Nasdaq: XNPT) announced today that it will present the following posters at the 65th Annual Meeting of the American Academy of Neurology in San Diego, California:
AP (arbaclofen placarbil)
Spasticity
• An Ongoing Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects with Spasticity Due to Multiple Sclerosis Session Info: Poster Session P03: March 19, 2:00 pm - 6:30 pm PT Poster #: P03.267
AP (arbaclofen placarbil)
Spasticity
• An Ongoing Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Arbaclofen Placarbil in Subjects with Spasticity Due to Multiple Sclerosis Session Info: Poster Session P03: March 19, 2:00 pm - 6:30 pm PT Poster #: P03.267
